Rebuttal From Dr Downey
- PMID: 35000703
- DOI: 10.1016/j.chest.2021.06.019
Rebuttal From Dr Downey
Comment in
-
Rebuttal From Dr Thursfield et al.Chest. 2022 Jan;161(1):25. doi: 10.1016/j.chest.2021.03.073. Chest. 2022. PMID: 35000704 No abstract available.
Comment on
-
POINT: In the Era of Cystic Fibrosis Transmembrane Regulator Protein Modulator Therapy, Are the Treatment Goals for Adults Now Different From Those for Children With Cystic Fibrosis? Yes.Chest. 2022 Jan;161(1):18-20. doi: 10.1016/j.chest.2021.05.070. Chest. 2022. PMID: 35000701 No abstract available.
-
COUNTERPOINT: In the Era of Cystic Fibrosis Transmembrane Regulator Protein Modulator Therapy, Are the Treatment Goals for Adults Now Different From Those for Children With Cystic Fibrosis? No.Chest. 2022 Jan;161(1):21-24. doi: 10.1016/j.chest.2021.06.018. Chest. 2022. PMID: 35000702 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources